Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2010
04/21/2010EP2176658A2 Methods for detection of immunosuppressant drugs
04/21/2010EP2176657A1 Measurement of sequestered carbon
04/21/2010EP2176654A1 Biosensor
04/21/2010EP2176644A2 Microelectronic sensor device with a modulated light source
04/21/2010EP2176643A1 Optical sensing system for liquid fuels
04/21/2010EP2176629A1 Liquid sensor
04/21/2010EP2176452A1 An indicating fiber
04/21/2010EP2176432A1 Method for detecting disease markers
04/21/2010EP2176409A1 Nucleic acid construct systems capable of diagnosing or treating a cell state
04/21/2010EP2176290A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety
04/21/2010EP2175932A1 New neuronal viability factor and use thereof
04/21/2010EP2175777A1 Osmometric heart monitoring device and methods
04/21/2010EP2175722A2 Patient selection and therapeutic methods using markers of prostaglandin metabolism
04/21/2010EP1708790B1 Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
04/21/2010EP1692517B1 Use of adam 12 for diagnosis of preeclampsia
04/21/2010EP1689288B1 Immunosorbent blood tests for assessing paroxysmal cerebral discharges
04/21/2010EP1654355B1 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
04/21/2010EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases
04/21/2010EP1594960B1 Human cyclooxygenase-3 and uses thereof
04/21/2010EP1592388B1 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin
04/21/2010EP1549957B1 Method for determining the susceptibility of a subject to infection
04/21/2010EP1535068B1 Devices and methods for detecting amniotic fluid in vaginal secretions
04/21/2010EP1416277B1 Carrier particle latex for assay reagent and assay reagent
04/21/2010EP1354204B2 Hcv antigen/antibody combination assay
04/21/2010EP1325113B1 Factor vii glycoforms
04/21/2010EP1231930B1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS
04/21/2010EP1066506B1 Method and apparatus for synthesis of arrays of dna probes
04/21/2010EP0922102B1 Hepatocyte growth factor receptor agonists and uses thereof
04/21/2010EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
04/21/2010CN201440140U Furacilinum metabolite ELISA assay kit
04/21/2010CN201440139U Semi-automatic tubular chemiluminescence immune assay instrument
04/21/2010CN201440138U Medical test piece bearing device
04/21/2010CN201440137U Material tone-quality test knocking tool
04/21/2010CN201439502U Buffer zone device for simulating non-point source pollution control
04/21/2010CN1987439B Production method of immobilized enzyme suitable for calorimetric pesticide quick detection
04/21/2010CN1987408B Freezing clamp for biological soft tissue stretching test
04/21/2010CN1935236B Quality control method for Chinese medicine injection preparation
04/21/2010CN1899283B Quality control method for medicinal composition containing artemisine
04/21/2010CN1890410B Method and apparatus for order control in a production process for a fiber product
04/21/2010CN1858593B Hydrophilic and phydrophobic mode sheet base special for biological chip
04/21/2010CN1854734B Testing mould system and its operating method for triaxial experimental disturbed soil testing piece
04/21/2010CN1811436B Method for detecting Ennoxacin and its special enzyme-linked immune reagent kit
04/21/2010CN1670529B Method for constructing Compound Xueshuantong preparation HPLC fingerprint pattern
04/21/2010CN1650027B Device and method for high-throughput quantification of mRNA from whole blood
04/21/2010CN1598564B Meter
04/21/2010CN101696977A Method for determining stage of neurofibrillary degeneration
04/21/2010CN101696976A Biochip analysis process and control method thereof
04/21/2010CN101696975A Membrane matrix protein chip for detecting mycotoxin and preparation method thereof
04/21/2010CN101696974A HLA antibody specificity detecting method, cell dish and reagent kit
04/21/2010CN101696973A Allergenic specific IgE antibody immunoassay detection kit and preparation method thereof
04/21/2010CN101696972A Antigen-antibody reaction-based controllable gold nanorod assembling method
04/21/2010CN101696971A Biochip analyzer and control system thereof
04/21/2010CN101696970A Method for detecting dose of polymer in modified asphalt based on penetration-temperature curve
04/21/2010CN101696969A Gray technology based comprehensive quality evaluation method of high-gloss inkjet paper
04/21/2010CN101696968A New method for monitoring heavy metal content in soil
04/21/2010CN101696967A Lake water texture and water quality monitoring system and method based on wireless sensing network
04/21/2010CN101696966A Butler-type GPS monitoring communication system
04/21/2010CN101696937A Optical biosensor
04/21/2010CN101696399A Porcine reproductive and respiratory syndrome virus M protein CTL cell epitopes and application thereof
04/21/2010CN101696397A Mesenchymal cells and osteoblasts from human embryonic stem cell
04/21/2010CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof
04/21/2010CN101696239A Human oocyte zona pellucida protein multi-epitope chimeric peptide antigen and preparation method thereof
04/21/2010CN101696231A Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein
04/21/2010CN101435768B Apparatus and method for detecting specific substance concentration in solution by optical mode
04/21/2010CA2641448A1 Synthetic antigen mimetics matrices immuno-reactive with rheumatoid arthritis auto-antibodies
04/20/2010US7702467 Molecular property modeling using ranking
04/20/2010US7702466 Systems and methods for selection of nucleic acid sequence probes
04/20/2010US7702187 Scanner for scanning items marked with near-infrared tags
04/20/2010US7702104 System and method for securing genomic information
04/20/2010US7700823 Using animal model which expresses mutated presenilin proteins as diagnostic tool in monitoring/screening modulator for treatment of nervous system disorders
04/20/2010US7700822 Preparing transgenic animal model for diagnosis, prevention and treatment of atherosclerosis, hormonal imbalances, nervous system, skin, cardiovascular, cancer and vision disorders; drug screening
04/20/2010US7700792 Highly active lysophosphatidic acid and method of screening therewith
04/20/2010US7700755 cytotoxins; host cells; vaccines; histology
04/20/2010US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer
04/20/2010US7700746 Matrix material comprising agarose linked di-and trisaccharides for use in blood, food, water and viruses filtering; protein separation
04/20/2010US7700744 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses
04/20/2010US7700743 A chromatography media such as silica controlled pore glass or agarose containing an affinity ligand such as 2-Aminobenzimidazole (ABI) or aminomethylbenzimidazole (AMBI); great degree of selectivity, particularly towards proteins such as IgG
04/20/2010US7700742 Antibodies to insulin-like growth factor I receptor
04/20/2010US7700736 PRO350 antibodies
04/20/2010US7700735 High potency recombinant antibodies and method for producing them
04/20/2010US7700727 Compositions and kits for detecting pathogen infection
04/20/2010US7700726 chemokines; open reading frames; long terminal repeats; site directed mutagenesis; antibodies
04/20/2010US7700725 HIV antisense proteins
04/20/2010US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells
04/20/2010US7700715 Kit for use in the diagnosis and treatment of cancer
04/20/2010US7700615 comprises 4-methyl-3-nitro-benzoic acid as inhibitor and 1,3-bis(2-chloroethyl)-1-nitrosourea as chemotherapeutic agent; for treatment of breast cancer and melanomas
04/20/2010US7700561 Abuse-resistant amphetamine prodrugs
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700554 Compositions for modulating blood-brain barrier transport
04/20/2010US7700548 Using granulocyte colony stimulating factor as therapeutic agent through a slow release mechanism, in treatment of spontaneous abortion, preeclampsia, preterm labor
04/20/2010US7700547 Preventing airway mucus production by administration of EGF-R antagonists
04/20/2010US7700524 Perfluoro sulfonyl halides and related species as polymer support modifiers
04/20/2010US7700375 bioassay with compounds having dimaleimide groups attached directly to fluorescent cores, whose latent fluorescence is quenched until maleimide groups undergo thiol addition reaction, for detecting target proteins having sterically unhindered sulfhydryl groups; fluorescence resonance energy transfer
04/20/2010US7700374 Device for capturing target substance
04/20/2010US7700373 Assay method and apparatus
04/20/2010US7700372 rapid assay of antigens, antibodies; pregnancy prognosis
04/20/2010US7700371 Using solid support comprising immobilized locked nucleic acids or peptide nucleic acid to identify preferential particles in solution
04/20/2010US7700368 plant extracts; obtaining ethanolic solution, passing through column of activated charcoal, and collecting the eluate, removing solvent by rotary evaporation, redissolving in methanol, filtering
04/20/2010US7700366 Thermally, photochemically, and chemically stable in thin films and soluble in organic solvents; photovoltaic devices; sensors; semiconductors
04/20/2010US7700364 Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry